References
- Loftsson T, Duchene D. Cyclodextrin and their pharmaceutical applications. Int J Pharm 2007;329:1–11.
- Sweetman S. Martindale: The complete drug reference. 34th ed. London: Pharmaceutical Press; 2005:11.
- Maffat AC, Ossdton MD, Widdop B. Clarke’s analysis of drugs and poison. Vol. 2, 3rd ed. London: Pharmaceutical Press; 1999:571.
- British Pharmacopoeia. London: Her Majesty Stationary Office; 2002:40–41.
- Higuchi T, Connors K. Phase-solubility techniques. In: Reilley CN, editor. Advanced Analytical Chemistry and Instruments. Vol. 4. New York: John Wiley and Sons; 1965:117–212.
- Liu L, Zhu S. Preparation and characterization of inclusion complexes of Prazosin hydrochoride with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. J Pharm Biomed Anal 2006;40:122–127.
- Zhao D, Liao K, Ma X, Yan X. Study of supramolecular inclusion of β-cyclodextrin with andrographolide. J Incl Phenom Macro Chem 2002;43:259–264.
- Moyano JR, Gins JM, Arias MJ, Rabasco AM. Study of the dissolution characteristics of oxazepamvia complexation with β-cyclodextrin. Int J Pharm 1995;114:95–102.
- Vavia PR, Adhage NA. β-cyclodextrin inclusion complexation by milling. Pharm Pharmacol Commun 2000; 6:13–18.
- Gerhard Vogel H. Drug discovery and evaluation. Pharmacological assays. 2nd ed. New York: Springer; 2002:715–716.